ModMed Acquires Bonsai Health, Igniting an AI Revolution in Healthcare

BOCA RATON, FL – April 20, 2026 – ModMed, a leading software provider for specialty medical practices, today announced its acquisition of Bonsai Health, a high-growth platform specializing in agentic artificial intelligence for patient engagement. The move marks a pivotal step in ModMed's ambition to create the 'AI-Powered Practice,' integrating powerful automation tools designed to redefine front-office efficiency and patient care coordination across its vast network.

This acquisition brings together ModMed’s established presence, serving nearly 50,000 providers, with Bonsai Health’s cutting-edge AI that automates patient reactivation and self-scheduling. The integration promises to accelerate a shift from manual, staff-driven administrative tasks to a proactive, automated system that works continuously behind the scenes.

"We are thrilled to welcome the incredible team at Bonsai Health into the ModMed family," said Dan Cane, co-Founder and co-CEO of ModMed, in the official announcement. "Bonsai was built on a simple but powerful mission: to ensure the right care happens at the right time. Their agentic AI platform and approach to patient reactivation are a perfect fit for our vision of the AI-Powered Practice."

The Dawn of the Autonomous Front Office

Before its acquisition, Bonsai Health had already carved out a unique niche in the health tech landscape. Founded in 2024 by Travis Schneider and Luke Kervin—veterans of the patient engagement space who previously co-founded PatientPop—Bonsai was built to solve the chronic front-office bottleneck that plagues medical practices. The company’s core innovation lies in its 'agentic AI' engine.

Unlike passive chatbots or simple reminder systems, this agentic AI functions as an autonomous workforce. It continuously scans a practice’s Electronic Health Record (EHR) data to identify care gaps—such as patients overdue for follow-ups—and matches those needs with open slots in a provider's schedule. The system then initiates personalized, multi-channel outreach via SMS and email to proactively engage patients and guide them to self-schedule appointments, all without requiring any manual staff intervention.

Bonsai's pre-acquisition performance metrics underscore the platform's efficacy. Having secured $7 million in seed funding in 2025, the company had already engaged over 235,000 patients, scheduled more than 36,000 appointments, and reportedly generated approximately $55.3 million in associated revenue for its clients. Testimonials from early adopters praised the system's ability to fill schedules and generate significant revenue "without lifting a finger," validating its promise to reduce staff workload while simultaneously boosting practice health.

"Joining the ModMed family provides us with the scale and resources of an industry leader to bring our AI technology to nearly 50,000 providers," stated Luke Kervin, co-Founder and co-CEO of Bonsai Health. "ModMed’s deep clinical datasets and industry-leading infrastructure provide the perfect environment to advance our agentic AI innovation faster than ever before."

A Strategic Play for Market Leadership

The acquisition is more than a technological upgrade; it is a calculated strategic move by ModMed, backed by its private equity partner, Clearlake Capital Group. It aims to solidify the company’s leadership position in the competitive specialty medical software market by creating a deeply integrated, AI-powered ecosystem that is difficult for competitors to replicate.

Bonsai’s proactive capabilities are designed to complement ModMed's existing patient engagement suite, Klara, which serves as a centralized hub for staff-managed communications. While Klara streamlines conversational workflows, Bonsai will add a powerful, autonomous layer that anticipates needs and takes action, effectively creating a two-pronged approach to patient engagement.

This strategy aligns perfectly with the investment thesis of Clearlake Capital. Paul Huber, Managing Director at Clearlake, noted the significance of the technology in the press release. "Agentic AI is transforming the front office in healthcare—shifting from reactive, staff-driven workflows to proactive, automated patient engagement at scale—and Bonsai Health is a best-in-class example of where this technology is headed," he said. This endorsement from the financial backer highlights a broader market trend: the future of practice management software lies in intelligent automation that delivers measurable return on investment.

The move is seen by industry observers as a consolidation of AI power that could set a new standard for what medical practices expect from their technology partners. By embedding Bonsai's AI, ModMed is not just selling software; it is offering a solution to systemic industry problems like staff burnout, patient non-adherence, and revenue leakage from unfilled schedules.

Reshaping the Practice and Patient Experience

The most significant impact of this acquisition will be felt on the front lines of healthcare—in the daily operations of specialty practices and the experiences of their patients. For practice administrators and staff, the integration of Bonsai's technology promises a dramatic reduction in the administrative burden of scheduling, managing follow-ups, and chasing down patients who have fallen out of care.

By automatically filling last-minute cancellations and proactively reactivating dormant patients, the AI engine directly addresses two major sources of lost revenue. This allows front-office staff to transition from repetitive, low-value tasks to more meaningful, high-touch interactions with the patients physically present in the office, improving both job satisfaction and the quality of in-person service.

For patients, the benefits are equally compelling. The system is designed to improve access to care by making it effortless to book an appointment at any time, without waiting for office hours or playing phone tag. More importantly, the proactive outreach for follow-up care helps ensure that patients adhere to their treatment plans, preventing small health issues from becoming major problems. In specialties like dermatology, ophthalmology, orthopedics, and gastroenterology—all core markets for ModMed—timely follow-up can be critical for managing chronic conditions and achieving positive long-term health outcomes.

As ModMed begins the aggressive rollout of this technology across its network, the deployment represents one of the largest real-world applications of agentic AI in healthcare to date. It moves the concept from a theoretical breakthrough to a practical, domain-specific tool with tangible implications for practice economics and patient well-being, setting a new benchmark for the future of healthcare administration.